Prevalence of Age-Related Macular Degeneration in Slovakia and Associated Risk Factors: A Mobile Clinic-Based Cross-Sectional Epidemiological Survey

REFERENCES

• Pascolini D, Mariotti SP. Global estimates of visual impairement: 2010. Br J Ophthalmol. 2012;96:614–8.
   PubMed Web of Science ®Google Scholar
• Resnikoff S, Pascolini D, Etya’ale D, Kocur I, Pararajasegaram R, Pokharel GP, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;82:844–51.
   PubMed Web of Science ®Google Scholar
• Augood CA, Vingerling JR, de Jong PT, Chakravarthy U, Seland J, Soubrane G, et al. Prevalence of age-related maculopathy in older Europeans: The European Eye Study (EUREYE). Arch Ophthalmol. 2006;124:529–35.
   PubMed Web of Science ®Google Scholar
• Khan M, Agarwal K, Loutfi M, Kamal A. Present and possible therapies for age-related macular degeneration. ISRN Ophthalmology. 2014;2014:608390.
   PubMedGoogle Scholar
• Dhoot DS, Kaiser PK. Ranibizumab for age-related macular degeneration. Expert Opin Biol Ther. 2012;12:371–81.
   PubMed Web of Science ®Google Scholar
• Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: A systematic review and meta-analysis. Lancet Global Health. 2014;2:e106–16.
   PubMed Web of Science ®Google Scholar
• Smith W, Assink J, Klein R, Mitchell P, Klaver CC, Klein BE, et al. Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology. 2001;108:697–704.
   PubMed Web of Science ®Google Scholar
• Clemons TE, Milton RC, Klein R, Seddon JM, Ferris FL 3rd; Age-Related Eye Disease Study Research Group. Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS), AREDS report no. 19. Ophthalmology. 2005;112:533–9.
   PubMed Web of Science ®Google Scholar
• Delcourt C, Diaz JL, Ponton-Sanchez A, Papoz L. Smoking and age-related macular degeneration: The POLA Study. Arch Ophthalmol. 1998;116:1031–5.
   PubMedGoogle Scholar
• Thornton J, Edwards R, Mitchell P, Harrison RA, Buchan I, Kelly SP. Smoking and age-related macular degeneration: A review of association. Eye (Lond). 2005;19:935–44.
   PubMed Web of Science ®Google Scholar
• Klaver CC, Wolfs RC, Assink JJ, van Duijn CM, Hofman A, de Jong PT. Genetic risk of age-related maculopathy: Population-based familial aggregation study. Arch Ophthalmol. 1998;116:1646–51.
   PubMedGoogle Scholar
• Scholl HPN, Fleckenstein M, Charbel Issa P, Keilhauer C, Holz FG, Weber BHF. An update on the genetics of age-related macular degeneration. Mol Vis. 2007;13:196–205.
   PubMed Web of Science ®Google Scholar
• Mitchell P, Smith W, Wang JJ. Iris color, skin sun sensitivity, and age-related maculopathy: The Blue Mountains Eye Study. Ophthalmology. 1998;105:1359–63.
   PubMed Web of Science ®Google Scholar
• Tomany SC, Klein R, Klein BE; Beaver Dam Eye Study. The relationship between iris color, hair color, and skin sun sensitivity and the 10-year incidence of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology. 2003;110:1526–33.
   PubMed Web of Science ®Google Scholar
• Ersoy L, Ristau T, Lechanteur YT, Hahn M, Hoyng CB, Kirchhof B, et al. Nutritional risk factors for age-related macular degeneration. Biomed Res Int. 2014;2014:413150.
   PubMedGoogle Scholar
• Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration: The International ARM Epidemiological Study Group. Surv Ophthalmol. 1995;39:367–74.
   PubMed Web of Science ®Google Scholar
• Jonasson F, Arnarsson A, Sasaki H, Peto T, Sasaki K, Bird AC. The prevalence of age-related maculopathy in Iceland: Reykjavik eye study. Arch Ophthalmol. 2003;121:379–85.
   PubMedGoogle Scholar
• Dóci J, Juhás T, Klisenbauer D, Dóra A. Blindness in Slovakia. Cesk Oftalmol. 1988;44:241–6 [in Slovak].
   PubMedGoogle Scholar
• Horii T, Murakami T, Nishijima K, Sakamoto A, Ota M, Yoshimura N. Optical coherence tomographic characteristics of microaneurysms in diabetic retinopathy. Am J Ophthalmol. 2010;150:840–8.
   PubMed Web of Science ®Google Scholar
• Thomas D, Duguid G. Optical coherence tomography: A review of the principles and contemporary uses in retinal investigation. Eye (Lond). 2004;18:561–70.
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology. 1992;99:933–43.
   PubMed Web of Science ®Google Scholar
• Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M. Age standardization of rates: A new WHO standard. http://www.who.int/healthinfo/paper31.pdf ( accessed on September 3, 2014).
   Google Scholar
• Vingerling JR, Dielemans I, Hofman A, Grobbee DE, Hijmering M, Kramer CF, et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology. 1995;102:205–10.
   PubMed Web of Science ®Google Scholar
• Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia: The Blue Mountains Eye Study. Ophthalmology. 1995;102:1450–60.
   PubMed Web of Science ®Google Scholar
• Ristau T, Ersoy L, Hahn M, den Hollander AI, Kirchhof B, Liakopoulos S, et al. Nongenetic risk factors for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2014;55:5228–32.
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Tomany SC, Cruickshanks KJ. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: The Beaver Dam eye study. Ophthalmology. 2003;110:1273–80.
   PubMed Web of Science ®Google Scholar
• Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration: A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology. 2000;107:2224–32.
   PubMed Web of Science ®Google Scholar
• Tomany SC, Wang JJ, Van Leeuwen R, Klein R, Mitchell P, Vingerling JR, et al. Risk factors for incident age-related macular degeneration: Pooled findings from 3 continents. Ophthalmology. 2004;111:1280–7.
   PubMed Web of Science ®Google Scholar
• Ebrahimi KB, Handa JT. Lipids, lipoproteins, and age-related macular degeneration. J Lipids. 2011;2011:802059.
   PubMedGoogle Scholar
• Hiratsuka Y, Li G. Alcohol and eye diseases: A review of epidemiologic studies. J Stud Alcohol. 2001;62:397–402.
   PubMed Web of Science ®Google Scholar
• Hill CF, Powers BW, Jain SH, Bennet J, Vavasis A, Oriol NE. Mobile health clinics in the era of reform. Am J Manag Care. 2014;20:261–4.
   PubMed Web of Science ®Google Scholar
• Hill C, Zurakowski D, Bennet J, Walker-White R, Osman JL, Quarles A, et al. Knowledgeable neighbors: A mobile clinic model for disease prevention and screening in underserved communities. Am J Public Health. 2012;102:406–10.
   PubMed Web of Science ®Google Scholar
• Doi H, Kunikata H, Kato K, Nakazawa T. Ophthalmologic examinations in areas of Miyagi prefecture affected by the great east Japan earthquake. JAMA Ophthalmol. 2014;132:874–6.
   PubMed Web of Science ®Google Scholar